Sponsors

Chromogranin A enzyme-linked immunosorbent assay

Cisbio Bioassays has launched Chromoa, its chromogranin A enzyme-linked immunosorbent assay (ELISA) diagnostic tool. The new kit complements Cisbio’s existing chromogranin A radioimmunoassay (RIACT) kit and can be used by all laboratories for the detection and monitoring of neuroendocrine tumours.

Chromoa is a highly sensitive monoclonal antibody-based assay used to identify increased protein levels in serum when a neuroendocrine tumour is present. The most common neuroendocrine tumours affect the adrenal gland, the pancreas and the digestive track.

Chromogranin A is an increasingly essential analyte for the detection and monitoring of such tumours as well as prostate cancer, which can evolve into an aggressive neuroendocrine form.

Chromoa offers the same reliable results but in an ELISA format. This new kit features a longer shelf life and offers easier stock management, making it a convenient time- and cost-saving alternative. Particularly suitable for laboratories that do not use radioactive kits, ELISA methods have been used for quantitative analysis for several decades and can be adopted by any laboratory.

www.iba-worldwide.com

Latest Issues

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026